KT
Kayak Therapeutics, Inc.
SEC filingBiotechnology · Austin, TX
Amount raised$25Msold at filing
Total offering$30M$5M still open
Investors in the raise137count reported to the SEC
FiledAug 21, 2026first sale May 12, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Conor RichardsonExecutive Officer
Josiah HornblowerExecutive Officer, Director
Taylor SchreiberDirector
Tyler BrousDirector
Executive officers, directors and promoters as listed on the Form D.